Effects of etanercept or infliximab treatment on lipid profile and insulin resistance in patients with refractory rheumatoid arthritis

被引：31
|
作者：
Seriolo, Bruno [1 ]
Paolino, Sabrina [1 ]
Ferrone, Carmela [1 ]
Cutolo, Maurizio [1 ]
机构：
[1] Univ Genoa, Dept Internal Med & Med Specialities, I-16132 Genoa, Italy
来源：
CLINICAL RHEUMATOLOGY | 2007年 / 26卷 / 10期
关键词：
Rheumatoid Arthritis; Insulin Resistance; Total Cholesterol; Infliximab; Rheumatoid Arthritis Patient;
D O I：
10.1007/s10067-007-0702-2
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：1799 / 1800
页数：2
相关论文
共 50 条
  • [31] GLYCEMIC PROFILE AND INSULIN RESISTANCE IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS
    Brandy-Garcia, A. M.
    Lorenzo Martin, A.
    Alonso Castro, S.
    Alperi Lopez, M.
    Ballina Garcia, F. J.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 293 - 293
  • [32] The Safety and Efficacy of Etanercept on Cardiac Functions and Lipid Profile in Patients With Active Rheumatoid Arthritis
    Senel, Soner
    Cobankara, Veli
    Taskoylu, Ozgur
    Karasu, Ugur
    Karapinar, Hekim
    Erdis, Eda
    Evrengul, Harun
    Kaya, Mehmet Gungor
    JOURNAL OF INVESTIGATIVE MEDICINE, 2012, 60 (01) : 62 - 65
  • [33] Significant effects of biologic therapy on lipid profiles and insulin resistance in patients with rheumatoid arthritis
    Der-Yuan Chen
    Yi-Ming Chen
    Tsu-Yi Hsieh
    Chia-Wei Hsieh
    Chi-Chen Lin
    Joung-Liang Lan
    Arthritis Research & Therapy, 17
  • [34] Significant effects of biologic therapy on lipid profiles and insulin resistance in patients with rheumatoid arthritis
    Chen, Der-Yuan
    Chen, Yi-Ming
    Hsieh, Tsu-Yi
    Hsieh, Chia-Wei
    Lin, Chi-Chen
    Lan, Joung-Liang
    ARTHRITIS RESEARCH & THERAPY, 2015, 17
  • [35] Infliximab and etanercept treatment in rheumatoid arthritis. A Swedish experience.
    Crnkie, M
    Mansson, N
    Saxne, T
    Geborek, P
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S227 - S227
  • [36] Relative cost of etanercept versus infliximab in the treatment of rheumatoid arthritis.
    Sweis, BP
    Ellman, CJ
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S44 - S44
  • [37] Use of infliximab in patients with systemic juvenile idiopathic arthritis refractory to etanercept
    Katsicas, MM
    Russo, RAG
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2005, 23 (04) : 545 - 548
  • [38] Use of adalimumab in patients with juvenile idiopathic arthritis refractory to etanercept and/or infliximab
    María M. Katsicas
    Ricardo A. G. Russo
    Clinical Rheumatology, 2009, 28 : 985 - 988
  • [39] Use of adalimumab in patients with juvenile idiopathic arthritis refractory to etanercept and infliximab
    Katsicas, M. M.
    Russo, R. A.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 551 - 552
  • [40] Use of adalimumab in patients with juvenile idiopathic arthritis refractory to etanercept and/or infliximab
    Katsicas, Maria M.
    Russo, Ricardo A. G.
    CLINICAL RHEUMATOLOGY, 2009, 28 (08) : 985 - 988
12345